Registration
VENN STRATEGIES for AVANIR PHARMACEUTICALS, INC.
Firm
Client
Income
—
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Access to and innovation in biopharmaceuticals, including through policies related to payment, pricing, and clinical trials.
| Lobbyist | Covered position, as disclosed |
|---|---|
| GRANT COUCH New | Leg. Aide - Sen. Ron Wyden (D-OR) |
| ELIZABETH LEE New | Leg. Aide - Sen. Baldwin (D-WI); Fellow - Sen. Clinton (D-NY) |
| STEPHANIE SILVERMAN New | — |
| MICHAEL SPIRA New | Chief of Staff- Rep. McCarthy (D-NY); Deputy Chief of Staff - Rep. Perlmutter (D-CO) |
Foreign entities
Foreign owners and affiliates the filer disclosed. Amounts are as declared on this filing.
| Entity | Country | Principal place of business | Ownership | Contribution declared |
|---|---|---|---|---|
| OTSUKA PHARMACEUTICALS CO., LTD | Japan | Japan | 100.0% | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.